Bank of New York Mellon Corp - NEON THERAPEUTICS INC ownership

NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100. A total of 44 filers reported holding NEON THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of NEON THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$184,000
+121.7%
69,630
-0.6%
0.00%
Q4 2019$83,000
-11.7%
70,031
+28.6%
0.00%
Q3 2019$94,000
-72.3%
54,443
-23.8%
0.00%
Q2 2019$339,000
+55.5%
71,443
+112.1%
0.00%
Q1 2019$218,000
+122.4%
33,688
+73.4%
0.00%
Q4 2018$98,000
-30.5%
19,427
+17.6%
0.00%
Q3 2018$141,00016,5220.00%
Other shareholders
NEON THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
TRV GP III, LLC 9,741,636$46,175,00019.63%
Endurant Capital Management LP 465,650$2,207,0000.87%
HARVARD MANAGEMENT CO INC 505,871$2,398,0000.59%
Partner Investment Management, L.P. 103,596$491,0000.52%
MEITAV INVESTMENT HOUSE LTD 639,465$3,002,0000.20%
Hillhouse Capital Management 399,308$1,893,0000.06%
ArrowMark Colorado Holdings LLC 703,375$3,334,0000.03%
PFM Health Sciences, LP 121,848$578,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 159,200$755,0000.01%
OXFORD ASSET MANAGEMENT LLP 77,024$365,0000.01%
View complete list of NEON THERAPEUTICS INC shareholders